Home
>
National Drug Code (NDC)
>
AVALIDE
AVALIDE - 55154-2023-8 - (IRBESARTAN AND HYDROCHLOROTHIAZIDE)
Drug Information of AVALIDE
| Product NDC: | 55154-2023 |
| Proprietary Name: | AVALIDE |
| Non Proprietary Name: | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 12.5; 150 mg/1; mg/1 & nbsp; IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AVALIDE
| Product NDC: | 55154-2023 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020758 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970930 |
Package Information of AVALIDE
| Package NDC: | 55154-2023-8 |
| Package Description: | 2430 TABLET in 1 BOTTLE, PLASTIC (55154-2023-8) |
NDC Information of AVALIDE
| NDC Code | 55154-2023-8 |
| Proprietary Name | AVALIDE |
| Package Description | 2430 TABLET in 1 BOTTLE, PLASTIC (55154-2023-8) |
| Product NDC | 55154-2023 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970930 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Strength Number | 12.5; 150 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
